Our strategy celebrates its one year anniversary
With almost 10 million deaths recorded in 2018 and tens of millions of sufferers diagnosed, cancer remains the second-leading cause of death globally. The fight against cancer is everyone’s business.
Over the past year, Candriam has enabled you to join the fight for life by investing in companies which are involved in combatting and preventing cancer.
The fund celebrates its one year anniversary today. Time for our first annual update:
- How did the fund perform in 2019?
- What were the key portfolio changes?
- What are the most profitable sub-sectors?
The two fund managers, Rudi Van den Eynde, Head of Thematic Global investments, and Servaas Michielssens, Senior Biotechnology Analyst, answer your questions.
|Download the interview|